NASDAQ:MRKR | News — Page 3 | Marker Therapeutics, Inc.

MRKR News — Page 3

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2002-05-14Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 1.
2002-02-13Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 1,7.
2001-07-05Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 2.
2001-05-31Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 6.
2001-04-16Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-K/AMarker Therapeutics, Inc. filed Form 8-K/A covering items 1,7.
2001-03-21Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 1,7.
2001-03-14Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 6.
2001-03-14Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 2,7.
2000-11-27Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 4,7.
2000-11-13Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 5.
2000-10-12Current reportSEC filingMarker Therapeutics, Inc. filed Form 8-KMarker Therapeutics, Inc. filed Form 8-K covering items 5,7.